This paper compared the size distribution, morphology, and microRNA (miRNA) expression of extracellular vesicles (EVs) isolated by ultracentrifugation rather than precipitation from plasma and urine and from prostate cancer patients compared to healthy males. The presence of PCR inhibitors was also investigated by dilution of the RNA extract.
Isolation of Extracellular Vesicles from Biological Fluids via the Aggregation-Precipitation Approach for Downstream miRNAs Detection.
Konoshenko MY, Lekchnov EA, Bryzgunova OE, Kiseleva E, Pyshnaya IA, Laktionov PP
Purpose
Conclusion
Transmission electron microscopy (TEM) and light scattering showed the isolation of EVs of 30-200 nm from plasma and urine, regardless of isolation method, but differences in EV size between isolation methods and fluid types were observed. Further, co-isolated small and large particles were observed regardless of isolation method.
Significantly higher cycle threshold (CT) values were found for miR-19b and miR-425 when EVs were isolated from plasma using precipitation rather than ultracentrifugation, but there was no differences in levels of miR-19b, miR-378a, or miR-425 from urine or miR-378a from plasma between isolation methods. Compared to EVs isolated from the urine of healthy patients, urine EVs from prostate cancer patients had higher CT values for miR-19b, miR-378a, and miR-425 but only the level of miR-378a differed in plasma EVs based on diagnosis. miR-378a CT values were lower in urine than plasma EVs, regardless of isolation method and patient diagnosis. In contrast, miR-425 values were higher in urine than plasma EVs but the difference was only significant when isolation was via precipitation. Dilution of the miRNA generally led to expected increases in CT values, but this was not found for EVs isolated from the urine of prostate cancer patients by ultracentrifugation, indicating the presence of a PCR inhibiter.
Studies (1)
Purpose
This study compared the size distribution, morphology, and microRNA (miRNA) expression of extracellular vesicles (EVs) isolated by ultracentrifugation rather than precipitation from plasma and urine and from prostate cancer patients compared to healthy males. The presence of PCR inhibitors was also investigated by dilution of the RNA extract. EDTA blood and urine were collected from 12 health male donors between 45-60 years of age and 12 prostate cancer patients between the ages of 54 and 77. Blood was centrifuged at 400 x g for 20 min at 4°C followed by recentrifugation of plasma at 800 x g for 20 min at 4°C and removal of cellular debris by centrifugation at 17,000 x g for 20 min at 4°C. Urine was centrifuged at 800 x g for 20 min at 24°C followed by removal of cellular debris by centrifugation at 17,000 x g for 20 min at 24°C. Following centrifugation, EVs were isolated by ultracentrifugation or by precipitation. The ultracentrifugation protocol consisted of dilution in PBS, centrifugation at 100,000 x g for 90 min at 18°C, resuspension in PBS, and recentrifugation under the same conditions to obtain a pellet. The precipitation protocol involved mixing urine or plasma with PEG and DEXB solution, incubation for 30 min at 4°C, and centrifugation at 17,000 x g for 20 min to obtain a pellet. Freshly isolated EVs were analyzed by transmission electron microscopy and dynamic light scattering. Pellets from both isolation methods were resuspended in PBS, snap-frozen in liquid nitrogen, and stored at -80°C. miRNA was isolated using guanidium thiocyanate and octanoic acid and precipitation with isopropanol.cel-miR-39-3p RNA was spiked in during the extraction after addition of the denaturation buffer . RNA was quantified by real-time qRT-PCR.
Summary of Findings
EVs of 30-150 nm were observed in specimens isolated from plasma and urine under TEM, regardless of isolation method. The majority of EVs were 30-100 nm and were spherical bubbles. However, while the highest percentage of EVs from plasma was 31-50 nm, the highest percentage of EVs from urine was 51-100 nm, regardless of patient diagnosis. EVs isolated from plasma by precipitation appeared more globular with darker membranes than those isolated by ultracentrifugation and some densification was also observed when EVs were isolated by precipitation from the plasma of prostate cancer patients. By light scattering analysis, the size distribution of the isolated EVs was broader when isolated by precipitation than by ultracentrifugation (150-300 nm versus 180-260 nm). The size distribution of exosomes isolated from plasma were 50-200 nm with more defined peaks noted when isolated via precipitation versus ultracentrifugation. Importantly, co-isolated small and large particles were observed using TEM as well as light scattering, regardless of isolation method.
ANOVA analysis showed a significant difference between isolation methods in levels of miR-19b (P<0.001) and miR-425 (P<0.001), with pairwise comparisons finding significantly higher CT values for miR-19b and miR-425 when EVs were isolated from plasma using precipitation rather than ultracentrifugation (P<0.01). In contrast, no differences in levels of miR-19b, miR-378a, or miR-425 from urine and miR-378a from plasma between isolation methods. Compared to EVs isolated from the urine of healthy patients, urine EVs from prostate cancer patients had higher CT values for miR-19b (P<0.01), miR-378a (P<0.01), and miR-425 (P<0.001). miR-378a CTs were higher in plasma EVs from prostate cancer donors. ANOVA found differences between plasma and urine in levels of mir-19b (P<0.05), miR-378a (P<0.001), and miR-42 (P<0.001) with a significant interaction between specimen type and isolation method found for miR-19b (P<0.05) and miR-425 (P<0.01). Pairwise analysis found significantly lower miR-378a CT values in urine than plasma EVs, regardless of isolation method and patient diagnosis (P<0.01). miR-425 values were higher in urine than plasma EVs but the difference was only significant when isolation was via precipitation (P<0.05). Dilution of the miRNA generally led to expected increases in CT values but this was not found for EVs isolated from the urine of prostate cancer patients by ultracentrifugation, indicating the presence of a PCR inhibiter.
Biospecimens
FluidPlasmaFluidUrinePreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNormalPlatforms
Cell count/volumeLight scatteringMorphologyElectron microscopyMorphologyLight scatteringRNAReal-time qRT-PCRCell count/volumeElectron microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition HealthyProstate cancerBiospecimen Acquisition Biospecimen location PlasmaUrineAnalyte Extraction and Purification Analyte isolation method PrecipitationUltracentrifugationReal-time qRT-PCR Specific Targeted nucleic acid miR-19b-3pmiR-378a-3pmiR-39-3pmiR-425-5pReal-time qRT-PCR Specific Template modification DilutedNot diluted